Results 31 to 40 of about 47,856 (273)

Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis [PDF]

open access: yes, 2018
Background Few risk factors have been identified for the development of calcinosis among patients with Juvenile Dermatomyositis, and currently no clinical phenotype has been associated with its development.
Al-Hammadi, Noor   +4 more
core   +2 more sources

Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients

open access: yesClinics
OBJECTIVES: To analyse the frequency of metabolic syndrome in young adult female dermatomyositis patients and its possible association with clinical and laboratory dermatomyositis-related features and serum adipocytokines.
Marilda Guimarães Silva   +3 more
doaj   +1 more source

SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report

open access: yesJTO Clinical and Research Reports, 2021
SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients with malignancy-associated dermatomyositis express a specific autoantibody pattern usually positive for anti–transcription intermediary factor 1-γ (TIF1-γ ...
Johnathan Arnon, MD   +4 more
doaj  

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers

open access: yesRespirology Case Reports, 2021
We report a case of anti‐transcriptional intermediary factor 1γ (TIF1γ) antibody‐positive dermatomyositis following durvalumab treatment. The patient was successfully treated with pulse steroid therapy, high‐dose intravenous immunoglobulin (IVIg), and ...
Ryosuke Imai   +2 more
doaj   +1 more source

Biomarkers in Inflammatory Myopathies – An Expanded Definition [PDF]

open access: yes, 2019
Biomarkers as parameters of pathophysiological conditions can be of outmost relevance for inflammatory myopathies. They are particularly warranted to inform about diagnostic, prognostic, and therapeutic questions.
Benveniste, Olivier   +2 more
core   +2 more sources

Dermatomyositis and HIV [PDF]

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2016
HIV has been linked to several autoimmune disorders since its emergence in the 1980s. By affecting different cells and pathways in the immune system, HIV induces the development of certain autoimmune diseases while prohibiting the emergence of others. Dermatomyositis has been rarely described in patients with HIV.
Jeffrey Lederman   +5 more
openaire   +5 more sources

Kutane Manifestationen der Dermatomyositis bei Menschen mit dunkler Haut: Ein Überblick über veröffentlichte Fälle [PDF]

open access: yesJ Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 8, Page 1009-1012, August 2025.
Akuffo‐Addo E   +4 more
europepmc   +2 more sources

Small cell lung cancer with dermatomyositis: a case report

open access: yesFrontiers in Oncology
Dermatomyositis represents an autoimmune disorder characterized by notable skin and muscular manifestations. The annual incidence of dermatomyositis stands at approximately (5~10)/1 million individuals.
Xiaomin Guan   +7 more
doaj   +1 more source

CORRELATIONS BETWEEN NAILFOLD CAPILLAROSCOPY FINDINGS AND DISTINCT CLINICAL FORMS OF JUVENILE DERMATOMYOSITIS [PDF]

open access: yesRomanian Journal of Rheumatology, 2019
Juvenile dermatomyositis is the most common idiopathic inflammatory myopathy in childhood. Nailfold capillaroscopy plays an important role in its assessment, being useful for diagnosis and follow-up.
Sigrid Covaci   +2 more
doaj   +1 more source

Polymyositis And Dermatomyositis - Inflammation, Muscle Structure & Immunosuppressive Treatment [PDF]

open access: yes, 2012
Polymyositis and dermatomyositis are chronic, inflammatory disorders characterized by muscle weakness, low muscle endurance and by inflammation in skeletal muscle tissues.
Loell, Ingela
core   +1 more source

Home - About - Disclaimer - Privacy